Skip to content

Subscriptions are live.

Plans
Logo

Why is $CLYM stock down today?

Climb Bio, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS

Why is $CLYM down today?

The likely driver

Clinical / FDA update
Climb Bio, Inc.: Climb Bio Announces CLYM116 Phase 1 Data Demonstrating Prolonged Half-Life and Best-In-Class APRIL Suppression Supporting Every-12-Week Dosing in IgA Nephropathy
SEC filing · Sep 3
Price
$10.79
Move today
-1.4%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
165
Market cap
$636M
Prev close
$10.94
Avg volume
1.4M

Nothing has triggered on CLYM yet in this session. Our scanner has flagged it 165 times in the last 30 days , most recently on October 2 for big percentage moves, unusual volume, which is why this page is here. See the full CLYM page for the chart and the alert history.

Earlier scanner activity on CLYM

  • Oct 2Unusual volume (RVOL) alert
  • Oct 2Unusual volume (RVOL) alert
  • Oct 2Unusual volume (RVOL) alert
  • Oct 1Big % mover alert
  • Oct 1Unusual volume (RVOL) alert
  • Oct 1Big % mover alert
  • Sep 30Big % mover alert
  • Sep 30Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $CLYM alerts the moment volume spikes

Be first to know when $CLYM makes an unusual move. Create a free account to track $CLYM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.